We investigated αVβ6-dependent adhesion signaling complexes and identified an αVβ6/HER2 cross-talk mechanism, which drives invasion and is dysregulated in trastuzumab-resistant HER2+ breast cancer cells. The gene discussed is ERBB2; the disease is breast cancer.